Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study
Collin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Translational Oncology
|
August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
Jonathan W Riess, Shaila Rahman, Waleed Kian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Nature Genetics
|
November 7, 2017
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M Blakely, Thomas B K Watkins, Wei Wu, et al.
JAMA Oncology
|
October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial
Nobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Nature Communications
|
May 3, 2024
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
Franziska Haderk, Yu-Ting Chou, Lauren Cech, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
M M Zheng, Y Xia, K Pan, et al.
Cancer Research
|
September 7, 2022
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer
Xing Yi Woo, Anuj Srivastava, Philip C Mack, et al.
Cancer
|
October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
Sarah Waliany, Alissa J Cooper, Stephen V Liu, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study
Collin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Translational Oncology
|
August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
Jonathan W Riess, Shaila Rahman, Waleed Kian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Nature Genetics
|
November 7, 2017
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M Blakely, Thomas B K Watkins, Wei Wu, et al.
JAMA Oncology
|
October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial
Nobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Nature Communications
|
May 3, 2024
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
Franziska Haderk, Yu-Ting Chou, Lauren Cech, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
M M Zheng, Y Xia, K Pan, et al.
Cancer Research
|
September 7, 2022
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer
Xing Yi Woo, Anuj Srivastava, Philip C Mack, et al.
Cancer
|
October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
Sarah Waliany, Alissa J Cooper, Stephen V Liu, et al.
Page
of 14